Merck & Co Inc

NYSE: MRK
$117.17
-$0.06 (-0.1%)
Closing Price on September 20, 2024

MRK Articles

The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
The Commerce Department reports that more than 15 million jobs could be affected by self-driving cars, many major hedge funds have sold shares of Apple and Facebook, and more headlines.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Merck, Johnson & Johnson, DuPont, and Verizon led the 20 stocks that were heading for a lower close just minutes before the closing bell.
Verizon, Boeing, Merck, and Disney were Thursday's leading DJIA gainers.
The July 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week: Caterpillar, DuPont, McDonald's, 3M, Boeing, Coca Cola,...
Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) in a close second....
A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the report's top picks: AbbVie, Eli Lilly, Merck, and Shire.
IBM, JPMorgan, Pfizer, and Merck were the poorest performing stocks among the Dow 30 on Monday.
The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
General Electric, Intel, Merck, and Disney led the DJIA to a lower close on Thursday.
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
Johnson & Johnson and Merck were the top performers among the Dow 30 stocks Thursday while Goldman Sachs and Wal-Mart were the big laggards.
The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.